代表性论著：
1) Yongjun Quan (第一作者，IF=5.8，JCR Q1); Hong Zhang; Mingdong Wang; Hao Ping; Visium spatial transcriptomics reveals intratumor heterogeneity and profiles of Gleason score progression in prostate cancer, iScience, 2023, 26(12): 10.1016/j.isci.2023.108429 (SCI论著)。
2) Yongjun Quan (第一作者，IF=6.0，JCR Q2); Hong Zhang; Mingdong Wang; Hao Ping; UQCRB and LBH are correlated with Gleason score progression in prostate cancer: Spatial transcriptomics and experimental validationUQCRB and LBH correlate with prostate cancer progression, Computational and Structural Biotechnology Journal, (2024) 3315–3326: doi:https://doi.org/10.1016/j.csbj.2024.08.026 (SCI论著)。
3) Yongjun Quan (第一作者，IF=5.8，JCR Q1); Mingdong Wang; Hong Zhang; Dan Lu; Hao Ping; Spatial transcriptomics identifies RBM39 as a gene a ssociated with Gleason score progression in prostate cancer, iScience, 2024, 27(12): 10.1016/j.isci.2024.111351 (SCI论著)。
4) Yongjun Quan (第一作者，IF=3.1，JCR Q2); Hao Ping; Mingdong Wang; Xiaodong Zhang; RNA-Sequencing Analysis Indicates That N-Cadherin Promotes Prostate Cancer Progression by the Epigenetic Modification of Key Genes, DNA and Cell Biology, 2023, 42(9): 10.1089/dna.2023.0089 (SCI论著)。
5) Yongjun Quan (第一作者，IF=9.2，JCR Q1); Xiaodong Zhang; William Butler; Zhen Du; Mingdong Wang; Yuexin Liu; Hao Ping; The role of N-cadherin/c-Jun/NDRG1 axis in the progression of prostate cancer, International Journal of Biological Sciences, 2021, 17(13): 3288-3304: doi: 10.7150/ijbs.63300 (SCI论著)。
6) Yongjun Quan (第一作者，IF=5.3，JCR Q2); Yun Cui; Wasilijiang Wahafu; Yuexin Liu; Hao Ping; Xiaodong Zhang; MLL5α activates AR/NDRG1 signaling to suppress prostate cancer progression, American journal of cancer research, 2020, 10(5): 1608-1629 (SCI论著)。
7) Yongjun Quan (第一作者，IF=4.7，JCR Q2); Xiaodong Zhang; Mingdong Wang; Hao Ping; Histone lysine methylation patterns in prostate cancer microenvironment infiltration: Integrated bioinformatic analysis and histological validation, Frontiers in oncology, 2022, 981226(2022): 10.3389/fonc.2022.981226 (SCI论著)。
8) Yongjun Quan (第一作者，IF=5.8，JCR Q1); Xiaodong Zhang; Hao Ping; Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation, Cancer Cell International, 2022, 22: 33(2022): 10.1186 s12935-021-02438-1 (SCI论著)。
9) Yongjun Quan (第一作者，IF=7.5，JCR Q1); Hongen Lei; Wasilijiang Wahafu; Yuexin Liu; Hao Ping; Xiaodong Zhang; Inhibition of Autophagy Enhances the Anticancer Effect of Enzalutamide on Bladder Cancer, Biomedicine & Pharmacotherapy, 2019, 120: 10.1016/j.biopha.2019.109490 (SCI论著)。
10) Yongjun Quan (第一作者，IF=1.6); Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Hyung Suk Kim; Ja Hyeon Ku ; Dose, duration and strain of bacillus Calmette– Guerin in the treatment of nonmuscle invasive bladder cancer, Medicine, 2017, 96(42): e8300: 10.1097/MD.0000000000008300 (期刊论文)。
